Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: "One theme Sen. Bernie Sanders has repeatedly touched on during his run for the Democratic nomination for president has been the high cost of prescription drugs. His comment during the Feb. 11 Democratic debate at the University of Wisconsin-Milwaukee was typical as he rattled off a list of problems with the U.S. health care system: ""In America, we pay, by far, the highest prices in the world for prescription drugs."" We asked the Sanders campaign for the source of his claim. We didn't get a response. So we searched on our own. One organization that tracks such things is the International Federation of Health Plans, based in London. Their latest price report, from 2013, lists eight common drugs. Compared with England, the Netherlands, Spain, Switzerland and Canada, U.S. prices were far higher, sometimes dramatically so. Consider Nexium, the medicine widely used to treat acid reflux. A prescription that would cost $60 or less in other countries costs, on average, $215 in the United States. And that's just the average. Prices vary widely in this country: In 5 percent of the cases, the cost was $395. ""What Bernie says is true. There's nowhere that pays the same price as America,"" said Tom Sackville, the federation's CEO. In addition, ""there is this huge variation in price across America. Anything above the average is quite unjustified. When you get up to the 95th percentile, you're talking grand robbery."" The findings were similar in an April 2013 study published in the journal Health Affairs, which looked at the prices of brand name drugs in the United States, United Kingdom, Switzerland, Germany, France, Canada and Australia. In each of the three years studied -- 2005, 2007 and 2010 -- U.S. prices were consistently higher. The one exception: Switzerland. In addition, researchers found that, between 2005 and 2010, ""the gap between the United States and other countries seemed to widen."" And it wasn't just new drugs being embraced first in the United States that was driving up costs. They concluded that ""prices for older products rose faster in the United States than in other countries."" But Joel Farley of the University of North Carolina at Chapel Hill's Eshelman School of Pharmacy cautioned that the rule doesn't always apply to generic drugs. A 2008 comparison of 19 generic drugs found that some U.S. prices were lower than Canadian prices. ""In some cases it has to do with availability,"" he said. In other cases, a country may set the drug price low and in that fixed-price market ""there's no incentive to go lower."" The Wall Street Journal published an analysis in December that concluded 98 percent of 40 top branded drugs were more expensive in the United States than in England. In Norway, 93 percent of the 40 top branded drugs cost less than in the United States. And in Ontario, a comparison of 30 drugs showed that U.S. prices were also higher for 93 percent of the products. Why are the brand name prices so much lower in other countries, and why is there so much variation in the United States? Big customers can negotiate big discounts. So the countries with socialized medicine have a lot of leverage at the negotiating table, the experts told us. In the United States, hospitals, wholesalers and insurance companies all do their own negotiations. The Veterans Administration can -- and does -- negotiate dramatically lower prices. Under Medicaid, the drug companies are required to provide their medicines at a price that's as low as it is for any of their regular customers. But Medicare has been prohibited by law from negotiating lower prices since 2006, and that's a huge chunk of the U.S. health care industry. (When Barack Obama was first running for president, he promised to repeal that Bush-era restriction, but then backed off in an attempt to get passage of the Affordable Care Act.) The pharmaceutical industry says it needs the extra income to pay for research to keep new, desperately needed drugs coming. But with everyone getting a bargain, Americans are financing that research for the rest of the world, experts told us. Yet there's another way to look at the issue, said Amitava Dasgupta, a clinical toxicologist at the University of Texas Health Science Center at Houston. The tablet that costs a dollar in the United States may only cost 20 cents in India, but that drug is far more expensive to the average person in India because their income is so much lower. ""The U.S. subsidizes research for the world,"" he said. ""But I would look at that as philanthropy."" Our ruling Sanders said, ""In America, we pay, by far, the highest prices in the world for prescription drugs."" When it comes to brand-name drugs, which yield the highest profit for the pharmaceutical industry, studies support Sanders' claim -- although not always on a drug-by-drug basis. In addition, the differences in price can be dramatic because the U.S. health care system is so splintered, and Medicare is prohibited by law from using its market share to bargain for lower prices. We found one study comparing the United States and Canada that found exceptions for generic drugs, where the profit margin is much lower and which make up a much smaller share of prescription drug spending. But on balance," Claim: In America, we pay, by far, the highest prices in the world for prescription drugs.
[A]: "Sanders said, ""In America, we pay, by far, the highest prices in the world for prescription drugs."" When it comes to brand-name drugs, which yield the highest profit for the pharmaceutical industry, studies support Sanders' claim -- although not always on a drug-by-drug basis. In addition, the differences in price can be dramatic because the U.S. health care system is so splintered, and Medicare is prohibited by law from using its market share to bargain for lower prices. We found one study comparing the United States and Canada that found exceptions for generic drugs, where the profit margin is much lower and which make up a much smaller share of prescription drug spending."


[Q]: Paragraph: The Supreme Judicial Court said MIT cannot be blamed for the death of 25-year-old Han Nguyen, who jumped from the top of a campus building minutes after a professor confronted him about an offensive email. But it found that schools can be liable if they fail to act after they become aware that a student has attempted suicide while enrolled, or shortly before entering, or learn that the student had threatened to commit suicide. Gary Pavela, a consultant on law and policy issues in higher education, said he’s unaware of another state appellate court that has explicitly found that universities have a duty to prevent suicide in limited cases and defines those circumstances. “This will be very newsworthy to colleges around the country,” said Pavela, who has written a book about the legal questions surrounding student suicides. Jeffrey Beeler, an attorney for Nguyen’s estate, said they were disappointed the court sided with MIT, but believe its ruling will nonetheless “save student lives going forward.” An MIT spokeswoman said in a statement that Nguyen’s death was a tragedy and students’ well-being is of “paramount importance to the school.” Spokeswoman Kimberly Allen said the school already offers a “robust network” of services for students and “continually considers ways to enhance those resources.” The court noted that Nguyen never told anyone at MIT that he planned to kill himself or tried to kill himself while enrolled at the school. Furthermore, he was living off campus instead of a dormitory under “daily observation,” the court said. But the judges said schools must take “reasonable measures” to help students they know have attempted suicide while at the school or have threatened to kill themselves. That would include initiating a suicide prevention protocol, getting the student in the care of a medical professional, or contacting police, fire or emergency medical personnel. “It requires the school to really have a lot of information that the suicide is likely and the reasonable measures that the school needs to take are not extremely onerous,” said Naomi Shatz, an attorney who’s not involved in the case. A group of 18 colleges and universities — including Harvard University and Boston College — told the court that holding MIT responsible for Nguyen’s death would have far-reaching consequences by causing officials with no medical expertise to overreact to concerns out of fear of liability. Nguyen’s professors shared concerns about his mental health in the months leading up to his death, and one encouraged his colleagues to pass him or they might have “blood on their hands.” In a telephone call 11 minutes before he killed himself, a professor “read him the riot act” over an email Nguyen sent to another MIT official that they believed was inappropriate, court records said. The family said that the school should have known that “mishandling this fragile student” would result in his suicide. But MIT said the school wasn’t aware of the severity of his condition, noting that he was treated by outside professionals and refused on-campus resources. None of the professionals who treated Nguyen while he was at MIT believed he was an imminent risk of killing himself, the school said. ___ Follow Alanna Durkin Richer at http://twitter.com/aedurkinricher . Read more of her work at http://bit.ly/2hIhzDb . Claim: Court says schools can be liable for suicides but clears MIT.
[A]: Schools can be held liable for student suicides in certain circumstances, Massachusetts’ highest court said Monday in a ruling that also cleared the Massachusetts Institute of Technology of responsibility for the death of a graduate student who killed himself on campus in 2009.


[Q]: Paragraph: KGW-TV reports a woman in her 40s was hospitalized for a lung injury after she reportedly vaped products containing nicotine and THC. The products were purchased at local licensed retailers, Clark County Public Health said. A medical provider reported the illness to health officals. As of Dec. 10, the CDC reports 2,409 hospitalized cases of vaping-associated lung injury and 52 deaths. In Washington, 21 cases have been reported in nine counties. “We still don’t know what is causing this outbreak, and there may be more than one cause,” said Dr. Alan Melnick, Clark County health officer and Public Health director. “People should not use any vapor products.” In Oregon, two people have died from a vaping-related illness, according to the Oregon Health Authority. Claim: Washington’s Clark County reports 1st vaping-related illness.
[A]:
Health officials say the first case of severe lung illness associated with vaping has been reported in Vancouver’s Clark County.